论文部分内容阅读
在电转复法尚未普及的情况下,联合用药消除心房颤动(房颤)有一定实际意义,并且对复窦后维持治疗业有一定价值。我们采用阿托品、异搏停相奎尼丁联合服药治疗4例房颤(男女各2,37~55岁,二尖辦狭窄2例,扩张型心肌病1例,食管癌手术后1例)获得初步成功。本法优点之一是:奎尼丁用量甚小,0.2~0.8克即能除颤。未见严重副作用。具体用药是:先用阿托品0.3mg tid并异搏停80mg tid 2~3天之后,再加用奎尼丁0.1~0.2克
In the case of electroporation method has not yet been widely used, the combination therapy to eliminate atrial fibrillation (atrial fibrillation) has some practical significance, and the treatment of complex sinus after the treatment has a certain value. We use atropine, verapamil quinidine combined medication for the treatment of four cases of atrial fibrillation (male and female of 2,37 to 55 years old, two cases of mitral stenosis, dilated cardiomyopathy in 1 case, 1 case of esophageal cancer surgery) were obtained Initial success. One of the advantages of this law is: quinidine dosage is very small, 0.2 to 0.8 grams that can defibrillation. No serious side effects. The specific medication is: first with atropine 0.3mg tid and stop bleeding 80mg tid 2 ~ 3 days, plus quinidine 0.1 ~ 0.2 grams